Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12985694 | 0.83 | CYP3A4 (0.35) | CYP3A4ALDH1A1KDM4EHSD17B10HTT | |
| SCHEMBL2067654 | 0.75 | DGAT1 (0.37) | CYP3A4 | |
| SCHEMBL7871957 | 0.68 | DPP4 (0.36) | ALDH1A1 | |
| SCHEMBL3293016 | 0.66 | ALDH1A1 (0.52) | CYP3A4ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL11015127 | 0.64 | SMN1; SMN2 (0.39) | CYP3A4ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL4074495 | 0.63 | HSD17B10 (0.40) | CYP3A4ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL9013438 | 0.62 | ALDH1A1 (0.37) | CYP3A4ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL12069180 | 0.62 | MAOB (0.42) | CYP3A4ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL11013415 | 0.61 | SMN1; SMN2 (0.37) | CYP3A4ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL11011350 | 0.61 | SMN1; SMN2 (0.37) | CYP3A4ALDH1A1KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010139747-A1 | 1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES | NOVARTIS AG (CH) | 2010-12-09 | — | — | WO | disclosed |